lung cancer | |||||
新闻 | |||||
Calithera Biosciences (CALA) Q4 2021 Earnings Call Transcript | The Motley Fool Specifically, with regard to the squamous lung cancer and NRF2 mutant subset, all these patients get tumor sequencing in the front line. And so, in ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment